These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 14691747)

  • 21. Cardiovascular protection by estrogen: a hemodynamic mechanism?
    Rozenberg S; Liebens I; Vandromme J; Hotimsky A; Van Rijsselberge M
    Int J Fertil Menopausal Stud; 1994; 39 Suppl 1():36-42. PubMed ID: 8199639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of cardiovascular events in early menopause: a possible role for hormone replacement therapy.
    Antonicelli R; Olivieri F; Morichi V; Urbani E; Mais V
    Int J Cardiol; 2008 Nov; 130(2):140-6. PubMed ID: 18617278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The role of estradiol metabolites in prevention of cardiovascular diseases by hormone substitution in postmenopause].
    Lippert TH; Seeger H; Mueck AO
    Zentralbl Gynakol; 1999; 121(10):467-72. PubMed ID: 10573819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hormonal supplement therapy in women: effects on the cardiovascular system].
    Maas AH; van Gilst WH; Verheugt FW
    Ned Tijdschr Geneeskd; 2001 Jan; 145(2):65-9. PubMed ID: 11225258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Timing of the vascular actions of estrogens in experimental and human studies: why protective early, and not when delayed?
    Lenfant F; Trémollières F; Gourdy P; Arnal JF
    Maturitas; 2011 Feb; 68(2):165-73. PubMed ID: 21167666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of estrogen and tumor necrosis factor alpha in endothelial cell migration and early stage of angiogenesis.
    Florian M; Florianova L; Hussain S; Magder S
    Endothelium; 2008; 15(5-6):265-75. PubMed ID: 19065318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of platelet aggregation and adenosine triphosphate release in vitro by 17beta-estradiol and medroxyprogesterone acetate in postmenopausal women.
    Bar J; Lahav J; Hod M; Ben-Rafael Z; Weinberger I; Brosens J
    Thromb Haemost; 2000 Oct; 84(4):695-700. PubMed ID: 11057872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression by 17beta-estradiol of monocyte adhesion to vascular endothelial cells is mediated by estrogen receptors.
    Mori M; Tsukahara F; Yoshioka T; Irie K; Ohta H
    Life Sci; 2004 Jun; 75(5):599-609. PubMed ID: 15158369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid-independent effects of an estrogen-statin combination: inhibition of expression of adhesion molecules and plasminogen activator inhibitor--I in human endothelial cell cultures.
    Seeger H; Wallwiener D; Mueck AO
    Climacteric; 2001 Sep; 4(3):209-14. PubMed ID: 11588944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cardiovascular disease as a current threat of older women. Relation to estrogens].
    Zárate A; Saucedo R; Basurto L; Martínez C
    Ginecol Obstet Mex; 2007 May; 75(5):286-92. PubMed ID: 17849811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen protects peripheral and cerebral blood vessels from toxicity of Alzheimer peptide amyloid-beta and inflammatory reaction.
    Thomas T; Rhodin JA; Sutton ET; Bryant MW; Price JM
    J Submicrosc Cytol Pathol; 1999 Oct; 31(4):571-9. PubMed ID: 10685397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex hormones and the cardiovascular system: effects on arterial function in women.
    Teede HJ
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):672-6. PubMed ID: 17581228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hormonal contraception and substitution therapy: the importance of progestogen for cardiovascular diseases].
    Kuhl H
    Geburtshilfe Frauenheilkd; 1992 Nov; 52(11):653-62. PubMed ID: 1452000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Platelet activation and endothelial factors in standard exercise test before and after menopause].
    Krzysiek J; Milewicz T; Dybkowski R; Janczak-Saif A; Dembińska-Kieć A; Anna AZ; Guevara I; Sztefko K; Radowicki S; Dubiel JS; Klimek R
    Przegl Lek; 2001; 58(5):419-25. PubMed ID: 11603175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins.
    Walsh BW; Schiff I; Rosner B; Greenberg L; Ravnikar V; Sacks FM
    N Engl J Med; 1991 Oct; 325(17):1196-204. PubMed ID: 1922206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormone replacement therapy and the cardiovascular system lessons learned and unanswered questions.
    Ouyang P; Michos ED; Karas RH
    J Am Coll Cardiol; 2006 May; 47(9):1741-53. PubMed ID: 16682298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitric oxide stimulatory and endothelial protective effects of idoxifene, a selective estrogen receptor modulator, in the splanchnic artery of the ovariectomized rat.
    Ma XL; Gao F; Yao CL; Chen J; Lopez BL; Christopher TA; Disa J; Gu JL; Ohlstein EH; Yue TL
    J Pharmacol Exp Ther; 2000 Nov; 295(2):786-92. PubMed ID: 11046119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogens and atherosclerosis: insights from animal models and cell systems.
    Nofer JR
    J Mol Endocrinol; 2012 Apr; 48(2):R13-29. PubMed ID: 22355098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogens and atherosclerosis.
    Arnal JF; Gourdy P; Elhage R; Garmy-Susini B; Delmas E; Brouchet L; Castano C; Barreira Y; Couloumiers JC; Prats H; Prats AC; Bayard F
    Eur J Endocrinol; 2004 Feb; 150(2):113-7. PubMed ID: 14763907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular effects of endogenous estrogen and hormone therapy.
    Bechlioulis A; Naka KK; Calis KA; Makrigiannakis A; Michalis L; Kalantaridou SN
    Curr Vasc Pharmacol; 2010 Mar; 8(2):249-58. PubMed ID: 19485910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.